Wells Fargo’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Wells Fargo’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,684	Closed	-$307K	–	6746
2015 Q1	$307K	Sell	6,684 -396,693	-98%	-$11.9M	﹤0.01%	4211
2014 Q4	$9.68M	Sell	403,377 -657	-0.2%	-$14.8K	﹤0.01%	1848
2014 Q3	$10.2M	Buy	404,034 +8,805	+2%	+$219K	﹤0.01%	1766
2014 Q2	$10.3M	Buy	395,229 +3,065	+0.8%	+$78.8K	﹤0.01%	1797
2014 Q1	$10.1M	Buy	392,164 +161,780	+70%	+$4.38M	﹤0.01%	1793
2013 Q4	$4.66M	Buy	230,384 +218,093	+1,774%	+$5.13M	﹤0.01%	2312
2013 Q3	$321K	Buy	+12,291	New	+$308K	﹤0.01%	3968

Wells Fargo's HPTX Position: Q2 2015 in Review

Wells Fargo sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 6,684 shares — an estimated $307K sold.

Wells Fargo first reported a position in HPTX in Q3 2013 and held it in 7 quarters. The position peaked at $10.3M in Q2 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Wells Fargo reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Wells Fargo sold 6,684 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $307K.
Wells Fargo first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
Wells Fargo's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $10.3M in Q2 2014.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Wells Fargo's 13F filing for Q2 2015, filed 14 Aug 2015.